These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23797577)

  • 1. A systematic review of health-related quality of life instruments in patients with cancer cachexia.
    Wheelwright S; Darlington AS; Hopkinson JB; Fitzsimmons D; White A; Johnson CD
    Support Care Cancer; 2013 Sep; 21(9):2625-36. PubMed ID: 23797577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review.
    Tarricone R; Ricca G; Nyanzi-Wakholi B; Medina-Lara A
    Crit Rev Oncol Hematol; 2016 Mar; 99():49-62. PubMed ID: 26775729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future care of patients with the cancer anorexia-cachexia syndrome.
    Del Fabbro E
    Am Soc Clin Oncol Educ Book; 2015; ():e229-37. PubMed ID: 25993178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cachexia and anorexia: cancer's covert killer.
    Davis MP; Dickerson D
    Support Care Cancer; 2000 May; 8(3):180-7. PubMed ID: 10789957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life across cancer cachexia stages.
    Kasvis P; Vigano M; Vigano A
    Ann Palliat Med; 2019 Jan; 8(1):33-42. PubMed ID: 30525763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
    Leśniak W; Bała M; Jaeschke R; Krzakowski M
    Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia.
    Wheelwright S; Darlington AS; Hopkinson JB; Fitzsimmons D; Johnson C
    Palliat Med; 2016 Feb; 30(2):149-60. PubMed ID: 26024885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cachexia assessment tools.
    Blum D; Strasser F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):350-5. PubMed ID: 21986911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
    Cabeza C; Corsi O; Pérez-Cruz P
    Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern management of the cancer anorexia-cachexia syndrome.
    Nelson KA
    Curr Oncol Rep; 2000 Jul; 2(4):362-8. PubMed ID: 11122866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cancer anorexia/cachexia.
    Loprinzi CL
    Support Care Cancer; 1995 Mar; 3(2):120-2. PubMed ID: 7773579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. North Central Cancer Treatment Group (NCCTG).
    Loprinzi CL
    J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.